Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (2354)	10/16/1997 11:44:00 AM
From: BLUE HORSE SHOE	of 6136

To all readers of this thread, I would like to introduce you to another company who you will be hearing alot about in the comming months. Immune Response Corporation -IMNR Is a biopharmaceutical company with proprietary technology in the areas of HIV, autoimmune disease, gene therapy, and cancer. The Company has ten potential products in varying stages of clinical trials, with one of its flagship products, Remune (targeting HIV), half-way through Phase III.Importantly, IMNR has no royalty partners for Remune and if successful will capture 100% of the revenue stream. I suggest that all interested shareholders in AGPH check out IMNR ASAP

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next